BRAFV600E or mutant MAP2K1 human CD341 cells establish Langerhans cell-like histiocytosis in immune-deficient mice

Anahita Rafiei; C. Matthias Wilk; Patrick M. Helbling; Renier Myburgh; Yasuyuki Saito; Eugenia Haralambieva; Davide Soldini; Rikhia Chakraborty; Miriam Merad; Carl E. Allen; Cesar Nombela-Arrieta; Markus G. Manz

doi:10.1182/BLOODADVANCES.2020001926

BRAFV600E or mutant MAP2K1 human CD341 cells establish Langerhans cell-like histiocytosis in immune-deficient mice

Anahita Rafiei
, C. Matthias Wilk
, Patrick M. Helbling
, Renier Myburgh
, Yasuyuki Saito
, Eugenia Haralambieva
, Davide Soldini
, Rikhia Chakraborty
, Miriam Merad
, Carl E. Allen
, Cesar Nombela-Arrieta
, Markus G. Manz

Marc and Jennifer Lipschultz Precision Immunology Institute

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Original language	English
Pages (from-to)	4912-4917
Number of pages	6
Journal	Blood Advances
Volume	4
Issue number	19
DOIs	https://doi.org/10.1182/BLOODADVANCES.2020001926
State	Published - Oct 2020

Access to Document

10.1182/BLOODADVANCES.2020001926

Cite this

Rafiei, A., Matthias Wilk, C., Helbling, P. M., Myburgh, R., Saito, Y., Haralambieva, E., Soldini, D., Chakraborty, R., Merad, M., Allen, C. E., Nombela-Arrieta, C., & Manz, M. G. (2020). BRAFV600E or mutant MAP2K1 human CD341 cells establish Langerhans cell-like histiocytosis in immune-deficient mice. Blood Advances, 4(19), 4912-4917. https://doi.org/10.1182/BLOODADVANCES.2020001926

@article{96556dcd344e46c0b2cd8bc27f9f3729,

title = "BRAFV600E or mutant MAP2K1 human CD341 cells establish Langerhans cell-like histiocytosis in immune-deficient mice",

author = "Anahita Rafiei and \{Matthias Wilk\}, C. and Helbling, \{Patrick M.\} and Renier Myburgh and Yasuyuki Saito and Eugenia Haralambieva and Davide Soldini and Rikhia Chakraborty and Miriam Merad and Allen, \{Carl E.\} and Cesar Nombela-Arrieta and Manz, \{Markus G.\}",

note = "Funding Information: This study was supported by the Swiss National Science Foundation (grants 310030B\_166673/1 and 310030\_184747/1), the University of Zurich Clinical Research Priority Program {\textquotedblleft}Human Hemato-Lymphatic Diseases,{\textquotedblright} and the National Institutes of Health, National Cancer Institute (grant CA156689) (M.G.M.).",

year = "2020",

month = oct,

doi = "10.1182/BLOODADVANCES.2020001926",

language = "English",

volume = "4",

pages = "4912--4917",

journal = "Blood Advances",

issn = "2473-9529",

number = "19",

}

Rafiei, A, Matthias Wilk, C, Helbling, PM, Myburgh, R, Saito, Y, Haralambieva, E, Soldini, D, Chakraborty, R, Merad, M, Allen, CE, Nombela-Arrieta, C & Manz, MG 2020, 'BRAFV600E or mutant MAP2K1 human CD341 cells establish Langerhans cell-like histiocytosis in immune-deficient mice', Blood Advances, vol. 4, no. 19, pp. 4912-4917. https://doi.org/10.1182/BLOODADVANCES.2020001926

TY - JOUR

T1 - BRAFV600E or mutant MAP2K1 human CD341 cells establish Langerhans cell-like histiocytosis in immune-deficient mice

AU - Rafiei, Anahita

AU - Matthias Wilk, C.

AU - Helbling, Patrick M.

AU - Myburgh, Renier

AU - Saito, Yasuyuki

AU - Haralambieva, Eugenia

AU - Soldini, Davide

AU - Chakraborty, Rikhia

AU - Merad, Miriam

AU - Allen, Carl E.

AU - Nombela-Arrieta, Cesar

AU - Manz, Markus G.

N1 - Funding Information: This study was supported by the Swiss National Science Foundation (grants 310030B_166673/1 and 310030_184747/1), the University of Zurich Clinical Research Priority Program “Human Hemato-Lymphatic Diseases,” and the National Institutes of Health, National Cancer Institute (grant CA156689) (M.G.M.).

PY - 2020/10

Y1 - 2020/10

UR - https://www.scopus.com/pages/publications/85095879289

U2 - 10.1182/BLOODADVANCES.2020001926

DO - 10.1182/BLOODADVANCES.2020001926

M3 - Article

C2 - 33035332

AN - SCOPUS:85095879289

SN - 2473-9529

VL - 4

SP - 4912

EP - 4917

JO - Blood Advances

JF - Blood Advances

IS - 19

ER -